Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Encompass Health Corporation shares valued at $66,480 were purchased by O’Connor Kevin J. on May 06. At $66.48 per share, O’Connor Kevin J. acquired 1,000 shares. The insider’s holdings grew to 3,436 shares worth approximately $0.18 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
Also, Williams Terrance purchased 354 shares, netting a total of over 20,040 in proceeds. Following the buying of shares at $56.61 each, the insider now holds 5,258 shares.
As published in their initiating research note from UBS on September 24, 2021, Encompass Health Corporation [EHC] has been a Buy and the price target has been revised to $98. This represents a 46.05% premium over Thursday’s closing price. Analysts at Raymond James upgraded the stock from ‘”an Outperform”‘ to ‘”a Strong buy”‘ outlook in a report released in early August. As of November 23, 2020, Barclays has increased its “an Equal weight” rating to a “an Overweight” for EHC.
Analyzing EHC’s Price Performance
On Thursday, Encompass Health Corporation [NYSE: EHC] plunged -0.90% to $52.87. The stock’s lowest price that day was $52.64, but it reached a high of $53.50 in the same session. During the last five days, there has been a surge of approximately 5.85%. Over the course of the year, Encompass Health Corporation shares have jumped approximately 1.89%. Shares of the company reached a 52-week high of $74.61 on 04/14/22 and a 52-week low of $44.33 on 07/01/22. A 50-day SMA is recorded $54.60, while a 200-day SMA reached $62.81. Nevertheless, trading volume fell to 1.73 million shares from 1.45 million shares the previous day.
Support And Resistance Levels for Encompass Health Corporation (EHC)
According to the 24-hour chart, there is a support level at 52.51, which, if violated, would cause prices to drop to 52.14. In the upper region, resistance lies at 53.37. The next price resistance is at 53.86. RSI (Relative Strength Index) is 70.27 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 2.09, which suggests the price will increase in the coming days. Percent R is at 15.40%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
Is Encompass Health Corporation subject to short interest?
Stocks of Encompass Health Corporation saw a sharp steep in short interest on Jul 14, 2022 dropping by -0.89 million shares to 2.28 million. Data from Yahoo Finance shows that the short interest on Jun 14, 2022 was 3.17 million shares. A decline of -39.04% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 2.14 of the overall float, the days-to-cover ratio (short ratio) decline to 2.14.
Which companies own the most shares of Encompass Health Corporation (EHC)?
According to The Vanguard Group, Inc. filings, the company currently owns 9,246,887 shares, which is about 9.27% of the total EHC shares outstanding. The investor’s shares have plunged by -23,430 from its previous 13-F filing of 9270317.0 shares. With the completion of the sale transaction, Wellington Management Co. LLP’s stake is now worth $496,210,033. BlackRock Fund Advisors acquire a 0.81% interest valued at $454.23 million while The Baupost Group LLC purchased a 2,283,900 stake. A total of -64,909 shares of Encompass Health Corporation were bought by JANA Partners LLC during the quarter, and 13,357 were bought by JPMorgan Investment Management, I. In its current portfolio, SSgA Funds Management, Inc. holds 2,733,254 shares valued at $153.2 million.
In terms of Encompass Health Corporation share price expectations, FactSet research, analysts set an average price target of $66.58 in the next 12 months, up nearly 18.09% from the previous closing price of $53.35. Analysts anticipate Encompass Health Corporation stock to reach $82.00 by 2022, with the lowest price target being $59.00. In spite of this, 13 analysts ranked Encompass Health Corporation stock as a Buy at the end of 2022.